Early versus later treatment start in multiple sclerosis: a register-based cohort study

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

(2018) Xavier Montalban et al.   Multiple Sclerosis Journal

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

(2018) Xavier Montalban et al.   Multiple Sclerosis Journal

Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study

(2017) Nils Koch-Henriksen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Safety concerns and risk management of multiple sclerosis therapies

(2016) P. Soelberg Sorensen   ACTA NEUROLOGICA SCANDINAVICA

Predictors of long-term disability accrual in relapse-onset multiple sclerosis

(2016) Vilija G. Jokubaitis et al.   ANNALS OF NEUROLOGY

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

(2016) Ludwig Kappos et al.   NEUROLOGY

The Danish Multiple Sclerosis Treatment Register

(2016) Melinda Magyari et al.   Clinical Epidemiology

Registers of multiple sclerosis in Denmark

(2015) N. Koch-Henriksen et al.   ACTA NEUROLOGICA SCANDINAVICA

Defining reliable disability outcomes in multiple sclerosis

(2015) Tomas Kalincik et al.   BRAIN

Defining high, medium and low impact prognostic factors for developing multiple sclerosis

(2015) Mar Tintore et al.   BRAIN

Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15

(2015) Ludwig Kappos et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator

(2015) Jacqueline Palace et al.   LANCET NEUROLOGY

New management algorithms in multiple sclerosis

(2014) Per Soelberg Sorensen   CURRENT OPINION IN NEUROLOGY

Can we measure long-term treatment effects in multiple sclerosis?

(2014) Maria Pia Sormani et al.   Nature Reviews Neurology

Interferon-beta and disability progression in relapsing-remitting multiple sclerosis

(2013) Jelena Drulovic et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis

(2012) Afsaneh Shirani et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique

(2012) Devon S Conway et al.   Multiple Sclerosis Journal

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs

(2012) H Tedeholm et al.   Multiple Sclerosis Journal

Survival in MS

(2012) D.S. Goodin et al.   NEUROLOGY

Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for Physicians

(2011) William H. Shrank et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

The Danish Civil Registration System

(2011) Carsten Bøcker Pedersen   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

(2009) M. Trojano et al.   ANNALS OF NEUROLOGY

Immortal Time Bias in Pharmacoepidemiology

(2007) S. Suissa   AMERICAN JOURNAL OF EPIDEMIOLOGY